Susan Molineaux, Calithera Biosciences CEO (Lightstone Ventures via Vimeo)
Calithera to shut down after failing to revive Takeda assets
Calithera Biosciences won’t make it to the second quarter.
After a November warning that it only had enough money to keep the lights on into …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
